e-Casos clínicos
Tratamiento del síndrome de Sézary con alemtuzumab: serie de 5 casos y revisión de la literatura
Treatment of Sézary Syndrome With Alemtuzumab: A Series of 5 Cases and a Review of the Literature
Leído
9771
Vecesse ha leído el artículo
2584
Total PDF
7187
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 69 | 2 | 71 |
| 2025 5 | 166 | 29 | 195 |
| 2025 4 | 183 | 46 | 229 |
| 2025 3 | 149 | 24 | 173 |
| 2025 2 | 168 | 30 | 198 |
| 2025 1 | 139 | 25 | 164 |
| 2024 12 | 142 | 30 | 172 |
| 2024 11 | 166 | 66 | 232 |
| 2024 10 | 130 | 45 | 175 |
| 2024 9 | 87 | 25 | 112 |
| 2024 8 | 122 | 47 | 169 |
| 2024 7 | 110 | 29 | 139 |
| 2024 6 | 157 | 32 | 189 |
| 2024 5 | 104 | 43 | 147 |
| 2024 4 | 95 | 19 | 114 |
| 2024 3 | 82 | 28 | 110 |
| 2024 2 | 88 | 25 | 113 |
| 2024 1 | 123 | 19 | 142 |
| 2023 12 | 95 | 18 | 113 |
| 2023 11 | 140 | 22 | 162 |
| 2023 10 | 100 | 21 | 121 |
| 2023 9 | 106 | 37 | 143 |
| 2023 8 | 105 | 15 | 120 |
| 2023 7 | 121 | 36 | 157 |
| 2023 6 | 132 | 43 | 175 |
| 2023 5 | 142 | 58 | 200 |
| 2023 4 | 102 | 29 | 131 |
| 2023 3 | 99 | 49 | 148 |
| 2023 2 | 89 | 23 | 112 |
| 2022 1 | 72 | 27 | 99 |
| 2022 12 | 112 | 31 | 143 |
| 2022 11 | 108 | 42 | 150 |
| 2022 10 | 153 | 38 | 191 |
| 2022 9 | 76 | 58 | 134 |
| 2022 8 | 122 | 56 | 178 |
| 2022 7 | 111 | 57 | 168 |
| 2022 6 | 110 | 39 | 149 |
| 2022 5 | 110 | 45 | 155 |
| 2022 4 | 127 | 50 | 177 |
| 2022 3 | 125 | 57 | 182 |
| 2022 2 | 78 | 28 | 106 |
| 2021 1 | 86 | 57 | 143 |
| 2021 12 | 86 | 40 | 126 |
| 2021 11 | 75 | 44 | 119 |
| 2021 10 | 95 | 44 | 139 |
| 2021 9 | 67 | 29 | 96 |
| 2021 8 | 86 | 24 | 110 |
| 2021 7 | 60 | 28 | 88 |
| 2021 6 | 94 | 37 | 131 |
| 2021 5 | 85 | 31 | 116 |
| 2021 4 | 141 | 59 | 200 |
| 2021 3 | 124 | 35 | 159 |
| 2021 2 | 104 | 33 | 137 |
| 2020 1 | 95 | 27 | 122 |
| 2020 12 | 69 | 28 | 97 |
| 2020 11 | 51 | 30 | 81 |
| 2020 10 | 68 | 30 | 98 |
| 2020 9 | 57 | 22 | 79 |
| 2020 8 | 60 | 37 | 97 |
| 2020 7 | 53 | 17 | 70 |
| 2020 6 | 80 | 39 | 119 |
| 2020 5 | 99 | 25 | 124 |
| 2020 4 | 67 | 26 | 93 |
| 2020 3 | 61 | 27 | 88 |
| 2020 2 | 13 | 8 | 21 |
| 2020 1 | 85 | 2 | 87 |
| 2019 12 | 8 | 11 | 19 |
| 2019 11 | 4 | 6 | 10 |
| 2019 10 | 6 | 12 | 18 |
| 2019 9 | 8 | 13 | 21 |
| 2019 8 | 4 | 11 | 15 |
| 2019 7 | 2 | 20 | 22 |
| 2019 6 | 6 | 21 | 27 |
| 2019 5 | 5 | 27 | 32 |
| 2019 4 | 3 | 5 | 8 |
| 2019 3 | 3 | 5 | 8 |
| 2019 2 | 2 | 4 | 6 |
| 2019 1 | 3 | 2 | 5 |
| 2018 12 | 2 | 3 | 5 |
| 2018 11 | 3 | 5 | 8 |
| 2018 10 | 2 | 1 | 3 |
| 2018 9 | 6 | 3 | 9 |
| 2018 8 | 0 | 10 | 10 |
| 2018 7 | 1 | 13 | 14 |
| 2018 6 | 0 | 10 | 10 |
| 2018 5 | 0 | 9 | 9 |
| 2018 4 | 1 | 2 | 3 |
| 2018 2 | 26 | 6 | 32 |
| 2018 1 | 30 | 8 | 38 |
| 2017 12 | 26 | 8 | 34 |
| 2017 11 | 47 | 9 | 56 |
| 2017 10 | 32 | 9 | 41 |
| 2017 9 | 22 | 18 | 40 |
| 2017 8 | 9 | 2 | 11 |
| 2017 7 | 2 | 1 | 3 |
| 2017 6 | 13 | 0 | 13 |
| 2017 5 | 6 | 1 | 7 |
| 2017 4 | 7 | 0 | 7 |
| 2017 3 | 2 | 1 | 3 |
| 2017 2 | 2 | 2 | 4 |
| 2016 1 | 7 | 1 | 8 |
| 2016 12 | 10 | 5 | 15 |
| 2016 11 | 11 | 15 | 26 |
| 2016 10 | 11 | 14 | 25 |
| 2016 9 | 0 | 18 | 18 |
| 2016 8 | 0 | 4 | 4 |
| 2016 7 | 12 | 6 | 18 |
| 2016 6 | 24 | 1 | 25 |
| 2016 5 | 20 | 3 | 23 |
| 2016 4 | 13 | 1 | 14 |
| 2016 3 | 10 | 11 | 21 |
| 2016 2 | 0 | 3 | 3 |
| 2015 1 | 0 | 1 | 1 |
| 2015 12 | 0 | 3 | 3 |
| 2015 11 | 0 | 1 | 1 |
| 2015 10 | 0 | 7 | 7 |
| 2015 9 | 0 | 10 | 10 |
Mostrar todo
